Inventor · disambiguated record
Chad Daniel Hopkins
Also filed as: HOPKINS CHAD DANIEL
14 granted patents·12 pending applications·14 citations·filing 2015–2024
87Inventor score
Top patents by PatentIndex Score
26 records- 0191US11261192B2Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Mar 1, 2022·5 cites·27 claims
- 0283US11065234B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·1 cites·32 claims
- 0382US11098030B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Aug 24, 2021·1 cites·13 claims
- 0482US10525036B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2016·Granted Jan 7, 2020·2 cites·23 claims
- 0580US2024391924A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 0677US10513509B2EGFR inhibitor compoundsKALYRA PHARMACEUTICALS INC·Filed 2017·Granted Dec 24, 2019·1 cites·24 claims
- 0776US10793504B2Methods for cross couplingRECURIUM IP HOLDINGS LLC·Filed 2017·Granted Oct 6, 2020·1 cites·22 claims
- 0875US10308609B2Bicyclic compoundsKALYRA PHARMACEUTICALS INC·Filed 2015·Granted Jun 4, 2019·2 cites·22 claims
- 0973US12049460B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted Jul 30, 2024·0 cites·20 claims
- 1073US2021330651A1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1172US10959989B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 30, 2021·0 cites·3 claims
- 1271US10975035B2Bicyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Apr 13, 2021·0 cites·25 claims
- 1371US10493060B2Spirocyclic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2019·Granted Dec 3, 2019·1 cites·11 claims
- 1470US11065233B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·0 cites·24 claims
- 1569US2022024939A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1663US2020268714A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1756US2019142811A1Estrogen receptor modulatorsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 1854US10653681B2Analgesic compoundsRECURIUM IP HOLDINGS LLC·Filed 2017·Granted May 19, 2020·0 cites·12 claims
- 1954US2023234956A1Methods of making wee1 inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 2053US2023212118A1Preparation of an selective estrogen receptor degraderRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 2146US11242327B2Analgesic compoundsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted Feb 8, 2022·0 cites·23 claims
- 2244US2021094899A1Acrylic acid analogsRECURIUM IP HOLDINGS LLC·Filed 2018·Application pending·0 cites
- 2339US2019083460A1Analgesic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 2439US2019060257A1Analgesic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 2539US2019099404A1Analgesic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 2636US2018201614A1Bicyclic compoundsKALYRA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chad Daniel Hopkins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →